Silexion Therapeutics Corp (SLXN) stock
SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
$1.65−0.11 (-6.25%)
Close on Nov 17, 2026Market cap $995.04KP/E –Yield –
Silexion Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Silexion Therapeutics's enterprise value was $1.58M on Nov 11, 2026, against $2.11B a year earlier. Over the last 3 years it ranged from -$4.08M to $488.16B, with a median of $365.88M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.58M | -99.9% |
| 2025 | Dec 31, 2025 | $1.43B | +139.7% |
| 2024 | Dec 31, 2024 | $597.15M | – |
See a number that looks wrong?